Is fear of disease progression associated with antiretroviral therapy adherence in persons with HIV/AIDS?

J Health Psychol. 2024 Aug;29(9):976-988. doi: 10.1177/13591053231224177. Epub 2024 Jan 22.

Abstract

We examined the mediating role of depression and anxiety on the relationship between fear of disease progression (FoP) and antiretroviral therapy (ART) adherence and the moderating role of social support in the FoP-depression/anxiety-ART adherence relationship in persons with HIV/AIDS (PWHA). 202 PWHA completed self-report measures. Simple mediation and moderated mediation analyses were performed. FoP was directly and negatively associated with ART adherence, and the mediating role of depression in this relationship was significant. Indirect effect of FoP mediated by anxiety on ART adherence was not significant. The moderating effect of social support was significant in the FoP-depression pathway, while the indirect effect of FoP on ART adherence mediated by depression was greatest at a higher level of social support and lower level of FoP. The results suggest the relevance of high FoP and depression-mediated FoP in ART adherence and social support may attenuate the negative impact of FoP.

Keywords: acquired immunodeficiency syndrome; adherence; antiretroviral therapy; anxiety; depression; fear of disease progression; human immunodeficiency virus; social support.

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / psychology
  • Adult
  • Anti-HIV Agents / therapeutic use
  • Anti-Retroviral Agents / therapeutic use
  • Anxiety
  • Assessment of Medication Adherence*
  • Depression*
  • Disease Progression*
  • Fear*
  • Female
  • HIV Infections* / drug therapy
  • HIV Infections* / psychology
  • Humans
  • Male
  • Medication Adherence* / psychology
  • Middle Aged
  • Social Support*

Substances

  • Anti-HIV Agents
  • Anti-Retroviral Agents